People

Des Jarlais
Don C. Des Jarlais, PhD
CDUHR - Co-Director & Associate Director, Infectious Disease Epidemiology and Social-behavioral Theory Core
NYU School of Global Public Health - Professor
Email: don.desjarlais@nyu.edu
Education
PhD, Social Psychology, University of Michigan, Ann Arbor
BA, Behavioral Science, Rice University
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Research synthesis
BIO
For over 30 years Don Des Jarlais has been conducting HIV/AIDS research among persons who inject drugs (PWID). He is PI of the “Risk Factors” study (R01DA003574), which was instrumental in tracking the HIV/AIDS epidemic in New York City. This study has been funded by the National Institute on Drug Abuse since 1983 and is the longest continuously funded study on HIV/AIDS in persons who use drugs. He has conducted HIV/AIDS research nationally (Seattle, CDC CIDUS studies, national syringe exchange survey) and internationally (in over 20 different countries). He has served as a consultant on these issues to the World Health Organization, the National Institutes of Health and the U.S. Centers for Disease Control and Prevention.
Projects
Principal Investigator, Risk Factors for AIDS among Persons Who Inject Drugs: HIV and COVID-19. Active
Principal Investigator, Barriers to Reason: Laws Impacting HIV Prevention Efforts among IDUs in the United States. Completed
Principal Investigator, Combined HIV Prevention for PWID and Future Collaborative Research in Vietnam. Completed
Principal Investigator, Combined Prevention to Reduce Initiation Into Injecting Drug Use. Completed
Principal Investigator, DRIVE (Drug Use and Blood-Borne Infections in Vietnam): Combined Prevention and Care to End the HIV Epidemic Among People Who Inject Drugs in Haiphong, Vietnam. Completed
Principal Investigator, Evaluating ART for All HIV Seropositives: Can It Work with the Hardest Cases?. Completed
Principal Investigator, Expanded Syringe Access Program: NY Evaluation (ESAP). Completed
Principal Investigator, HIV Infection in Ethnic Minority IDUs: An International Systematic Review. Completed
Principal Investigator, HIV Transmission among Injecting and Non-Injecting Drug Users in Tallinn, Estonia. Completed
Principal Investigator, Multiple HIV Prevention Packages for IDUs in Estonia. Completed
Principal Investigator, National Study of Syringe Exchange Programs. Completed
Principal Investigator, WHO Survey Coordinating Center, Drug Injecting Study – Phase 2. Completed
Publications

Recent

Bradley H, Luisi N, Carter A..., Hagan H..., Mateu-Gelabert P..., Des Jarlais DC (2024).
Assessing COVID-19 pandemic impacts on the health of PWID using a novel data sharing model
AIDS [Epub 2024 Nov 28]. doi: 10.1097/QAD.0000000000004076.

Healy E, Means AR, Knudtson K, Frank N, Juarez A, Prohaska S, McKnight C, Des Jarlais D, Asher A, Glick SN (2024).
Facilitators and barriers to monitoring and evaluation at syringe service programs
Harm Reduction Journal, 21 (1), 157. doi: 10.1186/s12954-024-01073-z. PMCID: PMC11351253.

Khezri M, McKnight C, Weng CA, Kimball S, Des Jarlais D (2024).
COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City
PLoS One, 19 (5), e0303394. doi: 10.1371/journal.pone.0303394. PMCID: PMC11093290.

Kimball S, Reynoso M, McKnight C, Des Jarlais D (2024).
Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: Systematic review and meta-analysis
PLoS One, 19 (4), e0302471. doi: 10.1371/journal.pone.0302471. PMCID: PMC11051606.

Salekesin M, Vorobjov S, Des Jarlais D, Uuskula A (2024).
Mortality among people who inject drugs – the interwoven roles of fentanyl and HIV: A community-based cohort study
European Journal of Public Health, 34 (2), 329-334. doi: 10.1093/eurpub/ckad204. PMCID: PMC10990538.


Notable

Des Jarlais DC, Huong DT (2018).
Ending HIV epidemics among people who inject drugs in LMICs
Lancet, 392 (10149), 714-719. doi: 10.1016/S0140-6736(18)31721-5.

Dr. Des Jarlais' ResearchGate Profile
Selected Press